Cargando…

Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland

BACKGROUND: While measuring, monitoring, and improving supply chain management (SCM) for antiretrovirals (ARVs) is understood at many levels of health systems, a gap remains in the identification and measurement of facility-level practices and behaviors that affect SCM. This study identifies practic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowser, Diana, Krech, Laura, Mabirizi, David, Chang, Angela Y., Kapaon, David, Bossert, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641807/
https://www.ncbi.nlm.nih.gov/pubmed/31249025
http://dx.doi.org/10.9745/GHSP-D-19-00063
_version_ 1783436859394752512
author Bowser, Diana
Krech, Laura
Mabirizi, David
Chang, Angela Y.
Kapaon, David
Bossert, Thomas
author_facet Bowser, Diana
Krech, Laura
Mabirizi, David
Chang, Angela Y.
Kapaon, David
Bossert, Thomas
author_sort Bowser, Diana
collection PubMed
description BACKGROUND: While measuring, monitoring, and improving supply chain management (SCM) for antiretrovirals (ARVs) is understood at many levels of health systems, a gap remains in the identification and measurement of facility-level practices and behaviors that affect SCM. This study identifies practices and behaviors that are associated with SCM of ARVs at the hospital level and proposes new indicators for measurement. METHODS: We performed an in-depth literature review to identify facility-level practices and behaviors and existing indicators that are associated with SCM. We used the United States Agency for International Development's 2013 National Supply Chain Assessment Toolkit to define 7 supply chain function areas to frame the study. Qualitative, semistructured key informant and focus group interviews were conducted in hospitals with health professionals from Cameroon, Namibia, and Swaziland to understand facility-level practices and behaviors. RESULTS: Using the results from 54 key informant and focus group interviews from 12 hospitals, we identified 30 practices and behaviors that may affect ARV SCM at the facility level. The following practice areas were particularly associated with SCM: order verification, actions taken when ARV stock is received, changes in prescription and dispensing due to ARV stock-out, actions to ensure patient adherence, and communication with other affiliated facilities and higher-level SCM. We subsequently developed measurable indicators for future research. CONCLUSION: This study characterizes facility-level practices and behaviors that can affect ARV SCM. It also identifies gaps in their measurement. While this study uses ARVs as a tracer medicine to understand gaps in practices at the facility level, many of the findings are more broadly applicable to other medicines in an integrated setting. This study provides real-world evidence and the groundwork for further research to characterize the link between 30 facility-level practices and behaviors and ARV SCM at the facility and central levels.
format Online
Article
Text
id pubmed-6641807
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-66418072019-07-29 Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland Bowser, Diana Krech, Laura Mabirizi, David Chang, Angela Y. Kapaon, David Bossert, Thomas Glob Health Sci Pract Original Articles BACKGROUND: While measuring, monitoring, and improving supply chain management (SCM) for antiretrovirals (ARVs) is understood at many levels of health systems, a gap remains in the identification and measurement of facility-level practices and behaviors that affect SCM. This study identifies practices and behaviors that are associated with SCM of ARVs at the hospital level and proposes new indicators for measurement. METHODS: We performed an in-depth literature review to identify facility-level practices and behaviors and existing indicators that are associated with SCM. We used the United States Agency for International Development's 2013 National Supply Chain Assessment Toolkit to define 7 supply chain function areas to frame the study. Qualitative, semistructured key informant and focus group interviews were conducted in hospitals with health professionals from Cameroon, Namibia, and Swaziland to understand facility-level practices and behaviors. RESULTS: Using the results from 54 key informant and focus group interviews from 12 hospitals, we identified 30 practices and behaviors that may affect ARV SCM at the facility level. The following practice areas were particularly associated with SCM: order verification, actions taken when ARV stock is received, changes in prescription and dispensing due to ARV stock-out, actions to ensure patient adherence, and communication with other affiliated facilities and higher-level SCM. We subsequently developed measurable indicators for future research. CONCLUSION: This study characterizes facility-level practices and behaviors that can affect ARV SCM. It also identifies gaps in their measurement. While this study uses ARVs as a tracer medicine to understand gaps in practices at the facility level, many of the findings are more broadly applicable to other medicines in an integrated setting. This study provides real-world evidence and the groundwork for further research to characterize the link between 30 facility-level practices and behaviors and ARV SCM at the facility and central levels. Global Health: Science and Practice 2019-06-24 /pmc/articles/PMC6641807/ /pubmed/31249025 http://dx.doi.org/10.9745/GHSP-D-19-00063 Text en © Bowser et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-19-00063
spellingShingle Original Articles
Bowser, Diana
Krech, Laura
Mabirizi, David
Chang, Angela Y.
Kapaon, David
Bossert, Thomas
Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland
title Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland
title_full Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland
title_fullStr Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland
title_full_unstemmed Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland
title_short Associations Between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland
title_sort associations between practices and behaviors at the health facility level and supply chain management for antiretrovirals: evidence from cameroon, namibia, and swaziland
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641807/
https://www.ncbi.nlm.nih.gov/pubmed/31249025
http://dx.doi.org/10.9745/GHSP-D-19-00063
work_keys_str_mv AT bowserdiana associationsbetweenpracticesandbehaviorsatthehealthfacilitylevelandsupplychainmanagementforantiretroviralsevidencefromcameroonnamibiaandswaziland
AT krechlaura associationsbetweenpracticesandbehaviorsatthehealthfacilitylevelandsupplychainmanagementforantiretroviralsevidencefromcameroonnamibiaandswaziland
AT mabirizidavid associationsbetweenpracticesandbehaviorsatthehealthfacilitylevelandsupplychainmanagementforantiretroviralsevidencefromcameroonnamibiaandswaziland
AT changangelay associationsbetweenpracticesandbehaviorsatthehealthfacilitylevelandsupplychainmanagementforantiretroviralsevidencefromcameroonnamibiaandswaziland
AT kapaondavid associationsbetweenpracticesandbehaviorsatthehealthfacilitylevelandsupplychainmanagementforantiretroviralsevidencefromcameroonnamibiaandswaziland
AT bossertthomas associationsbetweenpracticesandbehaviorsatthehealthfacilitylevelandsupplychainmanagementforantiretroviralsevidencefromcameroonnamibiaandswaziland